Blood Advances, 2473-9529

Journal

1 - 17 out of 17Page size: 50

Publications

  1. 2020
  2. Accepted/In press

    Heterozygous mutation SLFN14 K208N in mice mediates species-specific differences in platelet and erythroid lineage commitment: SLFN14 mediates lineage commitment in mice

    Christopher Smith, Elizabeth Haining, Sian Lax, Steve Watson, Abdullah Khan & Neil Morgan, 1 Dec 2020, (Accepted/In press) In: Blood Advances.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK cell lymphoma

    Rosemary Tierney, Andrew Bell, Heather Long, Claire Shannon-Lowe, 13 Oct 2020, In: Blood Advances. 4, 19, p. 4775-4787 13 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions

    Amanda Dalby, Jeremy Pike, Neil Morgan & Steve Watson, 14 Jul 2020, In: Blood Advances. 4, 13, p. 2953–2961 9 p.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines

    Alex Dowell, Graham Taylor, 28 Jan 2020, In: Blood Advances. 4, 2, p. 356-366 11 p.

    Research output: Contribution to journal › Article › peer-review

  6. 2019
  7. Published

    Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

    Sylvie Freeman, 22 Oct 2019, In: Blood Advances. 3, 20, p. 3052-3061 10 p.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells

    Francesca Kinsella, Jianmin Zuo, Charlotte Inman, Hayden Pearce, Suzy Eldershaw & Paul Moss, 12 Mar 2019, In: Blood Advances. 3, 5, p. 734-743 10 p.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR

    Suzy Eldershaw, Hayden Pearce, Nathaniel Davies & Paul Moss, 26 Feb 2019, In: Blood Advances. 3, 4, p. 519-530 12 p.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIba

    Caroline Kardeby, Elizabeth Haining, Ruben Barroso, Ed Rainger, Steve Watson, Yi Sun, 12 Feb 2019, In: Blood Advances.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα

    Caroline Kardeby, Elizabeth Haining, Ruben Barroso, Ed Rainger, Steve Watson, Yi Sun, 12 Feb 2019, In: Blood Advances. 3, 3, p. 275-287 13 p.

    Research output: Contribution to journal › Article › peer-review

  12. 2018
  13. Published

    TREM-like transcript 1: a more sensitive marker of platelet activation than P-selectin in humans and mice

    Zaher Raslan, Abdullah Khan, Yotis Senis & Alexandra Mazharian, 28 Aug 2018, In: Blood Advances. 2, 16, p. 2072-2078 7 p.

    Research output: Contribution to journal › Article › peer-review

  14. Published

    Evaluating measurable residual disease in acute myeloid leukemia

    Sylvie Freeman, 12 Jun 2018, In: Blood Advances. 2, 11, p. 1356-1366 11 p.

    Research output: Contribution to journal › Review article › peer-review

  15. Published

    C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia

    Justin Loke, Paulynn Suyin Chin, Peter Keane, Anna Pickin, Salam Assi, Anetta Ptasinska, Maria Imperato, Peter Cockerill & Conny Bonifer, 13 Feb 2018, In: Blood Advances. 2, 3, p. 271-284 14 p.

    Research output: Contribution to journal › Article › peer-review

  16. Published

    Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI

    Natalie Poulter, Rob Dinsdale, Peter Hampson, Jon Bishop, Tariq Iqbal, Steve Watson, Paul Harrison, 13 Feb 2018, In: Blood Advances. 2, 3, p. 240-251

    Research output: Contribution to journal › Article › peer-review

  17. 2017
  18. Published

    Fibrin and D-dimer bind to monomeric GPVI

    Marie Blanche Onselaer & Steve Watson, 22 Aug 2017, In: Blood Advances. 1, 19, p. 1495-1504

    Research output: Contribution to journal › Article › peer-review

  19. Published

    The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT

    Francesca Kinsella, Suzy Eldershaw, Charles Craddock, Jianmin Zuo, Ram Malladi & Paul Moss, 21 Aug 2017, In: Blood Advances. 1, 19, p. 1589-1597 9 p.

    Research output: Contribution to journal › Article › peer-review

  20. Published

    Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

    Charles Craddock, 28 Feb 2017, In: Blood Advances. 1, 7, p. 477-485

    Research output: Contribution to journal › Article › peer-review

  21. 2016
  22. Published

    Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia

    Paul Ferguson, Ikhlaaq Ahmed, Manoj Raghavan, Keith Wheatley & Charles Craddock, 27 Dec 2016, In: Blood Advances. 1, 3, p. 193-204 12 p.

    Research output: Contribution to journal › Article › peer-review